FERRING-PHARMACEUTICALS
Today is ‘World Sleep Day’ which was initiated by the World Association of Sleep Medicine (WASM) to acknowledge the importance of a good night’s sleep and the impact of sleep on health and quality of life. Sleep problems constitute a global epidemic that threatens health and quality of life for up to 45% of the world’s population4 .
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160317006004/en/
Despite this widespread issue much of the general public may be ignoring key triggers for disturbed sleep – with nocturia being the most common cause for a broken night’s sleep5 . Nocturia can be caused by an overproduction of urine at night or an overproduction of urine during the daytime and night time, which leads to having to get up in the night to go and empty the bladder6 .
Antonella Giannantoni, Editor of the Nocturia Resource Centre, an online resource intended for international healthcare professionals to increase awareness and knowledge about all aspects of Nocturia, said “We are very pleased that the importance of the impact that nocturia has on sleep is being recognised on World Sleep Day. Despite research clearly showing that nocturia is the most common cause of sleep disturbance, many people still ignore the obvious when it comes to a broken night’s sleep. It is time for the public to wake up to nocturia.”
This continued disturbance has a significant negative impact on our health in both the long and short term7,8,9,10 and can also be a symptom of serious health problems such as: diabetes, high blood pressure or cardiovascular disease11 .
Nocturia is not just isolated to a particular demographic: up to 60% of elderly men and women display symptoms of nocturia, but it can affect all ages as 30% of people over the age of 30 make at least two trips to empty their bladder every night12 . By ignoring simple signs such as this, the public are overlooking a problem that will only worsen over time and will continue to have a negative impact on quality of life and health. It is therefore important not to ignore a broken night’s sleep and to visit a doctor if one is having problems with getting up in the night due to the urge to go to the bathroom.
“Nocturia is a serious issue that should not go ignored by the public.” Said Philip van Kerrebroeck, Editor of the Nocturia Resource Centre, “It can affect anyone regardless of age or gender but the good news is that it is treatable. We would therefore encourage anyone who is losing sleep over these symptoms to speak to your doctor as soon as possible. There is no need to suffer in silence.”
Don’t settle for a bad night’s sleep and wake up to nocturia!
Could one be ignoring signs of nocturia? Take a look at these common sleep myths below and find out what to pay attention to:
Myth 1: One can "cheat" on the amount of sleep one is getting.
Truth : A common held belief is that one can catch up on any hours missed during the week by sleeping a few extra hours at the weekend.
Research has shown that one long night of sleep after a prolonged period of decreased sleep, can restore ones performance back to normal levels. However this effect may last as little as 6 hours after waking up. As the day goes on the person’s reaction times become about 10 times slower than what they were earlier in the day, increasing the risk of accidents and errors13 .
Myth 2: Insomnia is characterised only by difficulty falling asleep.
Truth : Difficulty falling asleep is one of four symptoms generally associated with insomnia. The others include waking up too early and not being able to fall back asleep, frequent awakenings, and waking up feeling unrefreshed. Insomnia can be a symptom of a sleep disorder or other medical or psychological/psychiatric problem, and can often be treated14 .
Myth 3: The older one becomes, the fewer hours of sleep one needs.
Truth : While sleep patterns change as we age, the amount of sleep we need generally does not. Older people may wake more frequently through the night and may actually get less night time sleep, but their sleep need is no less than younger adults. Because they may sleep less during the night, older people tend to sleep more during the day, which can affect their quality of life15 .
Myth 4: Drinking less water throughout the day, will decrease the times one goes to the toilet at night.
Truth : Drinking enough water every day is crucial to avoiding infections and keeping the body hydrated. Drinking fewer diuretics, like coffee or tea, as well as limiting fluid intake before bedtime, will help lessen the urge to go16 .
Myth 5: Going to the bathroom at night isn’t an issue until one has to go more than three times.
Truth: Going to the bathroom once or more a night regularly can be bothersome and is a condition called nocturia17 .
- Ends -
About Nocturia
Nocturia can be caused by an overproduction of urine at night or an overproduction of urine during the daytime and night time, which leads to having to get up in the night to go to the toilet18 . This is often explained by an abnormal rhythm of the body where large amounts of urine is excreted during sleep.
It can also be caused by external factors such as: excess fluids before bedtime, medications, alcohol, caffeine, or diuretic medications; in rare cases it could also be a symptom of something more serious such as: diabetes, high blood pressure or cardio vascular disease19 .
The broken night’s sleep caused by trips to the bathroom also leads to many short and long term health effects. In the short term lack of sleep can have a negative impact on our attention span, memory recall and learning20 . Longer term effects are being studied, but poor quality sleep or sleep deprivation has been associated with significant health problems, such as obesity, diabetes, weakened immune systems and even some cancers21,22,23 . Lack of sleep is also related to many psychological conditions such as depression, anxiety and psychosis24,25 .
About Ferring Pharmaceuticals:
Headquartered in Switzerland, Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group active in global markets. The company identifies, develops and markets innovative products in the areas of reproductive health, urology, gastroenterology, endocrinology and orthopaedics. Ferring has its own operating subsidiaries in nearly 60 countries and markets its products in 110 countries. To learn more about Ferring or its products please visit www.ferring.com .
World Sleep Day
World Sleep Day is an annual event to raise awareness of sleep disorders and the burden that they place on society. World Sleep Day 2016 will be held on Friday March 18, 2016.
For more information please visit www.worldsleepday.org .
References
1 Bladder and Bowel Foundation website. Bladder. Bladder Conditions and Symptoms. Nocturia page. [Last accessed March 2016] Available from: https://www.bladderandbowelfoundation.org/bladder/bladder-conditions-and-symptoms/nocturia/
2 Benefield LE. Facilitating Aging in Place: Safe, Sound, and Secure, An Issue of Nursing Clinics. 2014
3 Benefield LE. Facilitating Aging in Place: Safe, Sound, and Secure, An Issue of Nursing Clinics. 2014
4 Wade AG, Zisapel N, Lemoine P. Prolonged-release melatonin for the treatment of insomnia: targeting quality of sleep and morning alertness. Ageing Health 2008; 4 (1): 11-12
5 Benefield LE. Facilitating Aging in Place: Safe, Sound, and Secure, An Issue of Nursing Clinics. 2014
6 National Association for Continence website, Nocturia page. [Last Accessed February 2016] Available from: http://www.nafc.org/nocturia/
7 Orzel-Gryglewska, J. Consequenses of Sleep Deprivation. International Journal of Occupational Medicine and Environmental Health 2010; 23(1): 95-114. doi:10.2478/v10001-010-0004-9
8 Taheri S, Lin L, Austin D et al. Short sleep duration is associated with elevated ghrelin, reduced leptin and increased body mass index. PLoS Med 2004; 1(3): e62
9 Gottlieb DJ, Punjabi NM, Newman AB et al. Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med 2005; 165(8): 863-7
10 Meier-Ewert HK et al. Effect of Sleep Loss on C-Reactive Protein, an Inflammatory Marker of Cardiovascular Risk. Journal of the American College of Cardiology. 2004; 43(4). doi:10.1016/j.jacc.2003.07.050
11 National Association for Continence website, Nocturia page. [Last Accessed February 2016] Available from: http://www.nafc.org/nocturia/
12 Bosch JL, Weiss JP. The prevalence and causes of nocturia. J Urol 2010 Aug; 184(2): 440-6. doi:10.1016/j.juro.2010.04.011.
13 Cohen DA, Wang W, Wyatt JK, Kronauer RE, Dijk D-J, Czeisler CA, Klerman CA. Uncovering Residual Effects of Chronic Sleep Loss on Human Performance. Science Translational Medicine, Vol. 2, Issue 14, p. 14ra3, 13 January 2010. doi: 10.1126/scitranslmed.3000458
14 Sleep Foundation website, What is Insomnia? [Last Accessed February 2016] Available from: https://sleepfoundation.org/insomnia/content/what-is-insomnia
15 Vitiello MV. Recent Advances in Understanding Sleep and Sleep Disturbances in Older Adults, Growing Older Does Not Mean Sleeping Poorly. Current Directions in Psychological Science. 2009; December: Vol.18. no. 6, 316-320
16 National Association for Continence website, Nocturia page. [Last Accessed February 2016] Available from: http://www.nafc.org/nocturia/
17 Kerrebroeck P van, Abrams P, Chaikin D, Donovan J, Fonda D, Jackson S, Jennum P, Johnson T, Lose G, Mattiasson A, Robertson G, Weis J. The Standardisation of Terminology in Nocturia: Report from the Standardisation Sub-committee of the International Continence Society. Neurourology and Urodynamics. 2002; 00:179-183. doi: 10.1002/nau.10053
18 National Association for Continence website, Nocturia page. [Last Accessed February 2016] Available from: http://www.nafc.org/nocturia/
19 National Association for Continence website, Nocturia page. [Last Accessed February 2016] Available from: http://www.nafc.org/nocturia/
20 Orzel-Gryglewska, J. Consequenses of Sleep Deprivation. International Journal of Occupational Medicine and Environmental Health 2010; 23(1): 95-114. doi:10.2478/v10001-010-0004-9
21 Taheri S, Lin L, Austin D et al. Short sleep duration is associated with elevated ghrelin, reduced leptin and increased body mass index. PLoS Med 2004; 1(3): e62
22 Gottlieb DJ, Punjabi NM, Newman AB et al. Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med 2005; 165(8): 863-7
23 Meier-Ewert HK et al. Effect of Sleep Loss on C-Reactive Protein, an Inflammatory Marker of Cardiovascular Risk. Journal of the American College of Cardiology. 2004; 43(4). doi:10.1016/j.jacc.2003.07.050
24 Neckelmann D, Mykletun A, Dahl, AA. Chronic Insomnia as a Risk Factor for Developing Anxiety and Depression. Sleep 2007, 30(7): 873-880
25 Petrovsky N et al. Sleep Deprivation Disrupts Prepulse Inhibition and Induces Psychosis-Like Symptoms in Healthy Humans. The Journal of Neuroscience 2014; July, 34(27)-913409140
View source version on businesswire.com: http://www.businesswire.com/news/home/20160317006004/en/
Contact:
Ferring Pharmaceuticals
Helen Gallagher
Tel. +41 58 301 00 51
helen.gallagher@ferring.com
or
Nicole
Barraud-Estoppey
Tel. +41 58 301 00 53
nicole.barraud-estoppey@ferring.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex Presents New Data on Benefits of ALYFTREK® and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference6.6.2025 18:00:00 CEST | Press release
- Oral presentation on outcomes following treatment with CFTR modulators show that improvements in CFTR function, as measured by lower sweat chloride, correlate with better outcomes for people with cystic fibrosis - - Oral presentation on new post hoc data from randomized, controlled and open-label trials suggest improved quality of life results with ALYFTREK compared to TRIKAFTA® – Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data across multiple studies demonstrating positive clinical and quality of life benefits of treatment with CFTR modulators and, in particular, ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), which is approved in the United States and United Kingdom and is currently under review with health authorities in the EU, Canada, Australia, New Zealand and Switzerland. These data were presented at this year’s European Cystic Fibrosis Society’s (ECFS) 48th European Cystic Fibrosis Conference held June 4-7, 2025, in Milan, Italy. During the conferenc
Andersen Consulting tilføjer dimension med David and Golyat6.6.2025 16:33:00 CEST | Pressemeddelelse
Andersen Consulting udbygger sin globale konsulentkapacitet gennem en samarbejdsaftale med David and Golyat, en filippinsk konsulentvirksomhed inden for digital strategi. Med et stærkt fokus på business intelligence, kundeindsigt og digital first-eksekvering arbejder David and Golyat med kunder på tværs af flere sektorer – herunder regeringer, udviklingsorganisationer og private virksomheder – for at skabe langsigtet værdi gennem datainformerede beslutninger. Miko David, administrerende partner i David and Golyat, siger: "Vi ser frem til samarbejdet med Andersen Consulting, da det er en milepæl i vores vækstforløb. Ved at kombinere vores ekspertise inden for digital strategi og Andersen Consultings globale platform er vi i stand til at levere endnu større værdi til kunder, der navigerer på komplekse markeder." "Dette samarbejde betyder, at vi kan tilføre en ekstra dimension til vores globale konsulentplatform," siger Mark L. Vorsatz, global bestyrelsesformand og administrerende direktø
IBSA Derma at IMCAS Asia 2025: spotlight on the future of aesthetic medicine in the 10th Anniversary Year of NAHYCO® Technology6.6.2025 16:00:00 CEST | Press release
IBSA Derma, the dermoaesthetic division of Swiss company IBSA, will participate in the 18th IMCAS Asia Congress in Bangkok, gathering over 3,000 professionals from across the region to explore the future of aesthetic and regenerative medicine.With the presence in the Congress and a dedicated scientific symposium, the company reaffirms its commitment to advancing bioremodeling approaches and promoting a holistic, science-driven vision of authentic beauty.This year marks a key milestone for IBSA Derma: 10 years of NAHYCO® Technology, a patented innovation in hyaluronic acid science that continues to shape the future of tissue regeneration. IBSA Derma – the dermoaesthetic division of IBSA – once again confirms its leadership in the international aesthetic medicine landscape by participating in the 18th edition of IMCAS Asia, taking place from June 6 to 8 in Bangkok, Thailand. With over 3,000 attendees expected, the event represents a key opportunity for physicians and experts to share the
HistoSonics Completes Enrollment in #HOPE4KIDNEY Trial Evaluating Non-Invasive Histotripsy to Treat Kidney Tumors6.6.2025 14:00:00 CEST | Press release
Pivotal Study Advances to Establish Histotripsy as a Non-Thermal, Surgery-Free Alternative to Destroy and Liquefy Kidney Tumors HistoSonics, Inc., the manufacturer of the Edison® Histotripsy System and novel histotripsy therapy platforms, today announced the completion of patient enrollment in its pivotal #HOPE4KIDNEY trial. This prospective, multi-center, single-arm trial is designed to evaluate the safety and effectiveness of the Edison System in destroying kidney tissue by treating primary solid kidney tumors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606659747/en/ Edison Histotripsy System Procedure for Kidney Tumor Animation The trial enrolled patients with a single, non-metastatic solid kidney mass ≤3 cm, confirmed by imaging and biopsy. Subjects will be followed for five years post-procedure, with evaluations at multiple time points, including 14-day, 30-day, 90-day, 180-day, and annual assessments. The Edison
Norwegian Tech Firm Builds Military Command Center in 24 Hours6.6.2025 13:45:00 CEST | Press release
Norwegian technology provider Cyviz has successfully developed a fully mobile and ballistic-proof command center - designed, configured, and made operational in just 24 hours. The solution was showcased during a military exercise led by the Dutch Ministry of Defence and has already sparked interest from NATO members and civil protection agencies across Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606640770/en/ Cyviz demonstrates rapid deployment capability with a mobile, container-based control room for defense and crisis response Cyviz and its partners constructed the command room inside a 14-ton container designed for transport on standard military vehicles and resistant to machine gun fire. The unit was deployed at a military base in the Netherlands, where Cyviz was tasked with delivering a fully functional command-and-control environment, under strict time constraints and in a high-stakes simulation. "You do
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom